Paper37699201
Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD.
Patel BK and 10 others. Blood, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD. Papers, record 37699201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37699201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Humans | |
| Transcriptome | |
| Immunity, Cellular | |
| Steroids | |
| Intestinal Mucosa | |
| Acute Disease |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 CA228963 | NCI NIH HHS | United States | U01CA228963 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 37995106 | A potential tissue-based biomarker in gut GVHD. | https://conductscience.org/library/papers/37995106 |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25202122 | USP17- and SCFβTrCP--regulated degradation of DEC1 controls the DNA damage response. | Mol Cell Biol | 2014 | https://conductscience.org/library/papers/25202122 | PubMed |
| 2 | 29171820 | Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. | N Engl J Med | 2017 | https://conductscience.org/library/papers/29171820 | PubMed |
| 3 | 11231887 | Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. | BMC Physiol | 2001 | https://conductscience.org/library/papers/11231887 | PubMed |
| 4 | 23148523 | Visualising associations between paired 'omics' data sets. | BioData Min | 2012 | https://conductscience.org/library/papers/23148523 | PubMed |
| 5 | 29785172 | Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence. | Mediators Inflamm | 2018 | https://conductscience.org/library/papers/29785172 | PubMed |
| 6 | 27044258 | Cellular localization of guanylin and uroguanylin mRNAs in human and rat duodenal and colonic mucosa. | Cell Tissue Res | 2016 | https://conductscience.org/library/papers/27044258 | PubMed |
| 7 | 32242050 | Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. | Leukemia | 2020 | https://conductscience.org/library/papers/32242050 | PubMed |
| 8 | 32908315 | Combined whole-mount fluorescence in situ hybridization and antibody staining in zebrafish embryos and larvae. | Nat Protoc | 2020 | https://conductscience.org/library/papers/32908315 | PubMed |
| 9 | 24777184 | Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. | Bone Marrow Transplant | 2014 | https://conductscience.org/library/papers/24777184 | PubMed |
| 10 | 31816061 | The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. | Blood Adv | 2019 | https://conductscience.org/library/papers/31816061 | PubMed |
| 11 | 36095841 | Effective treatment of low-risk acute GVHD with itacitinib monotherapy. | Blood | 2023 | https://conductscience.org/library/papers/36095841 | PubMed |
| 12 | 29545329 | MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. | Blood | 2018 | https://conductscience.org/library/papers/29545329 | PubMed |
| 13 | 30504314 | GVHD: biology matters. | Hematology Am Soc Hematol Educ Program | 2018 | https://conductscience.org/library/papers/30504314 | PubMed |
| 14 | 31738834 | Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial. | Blood | 2020 | https://conductscience.org/library/papers/31738834 | PubMed |
| 15 | 26687425 | A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. | Lancet Haematol | 2015 | https://conductscience.org/library/papers/26687425 | PubMed |
| 16 | 20388871 | The best endpoint for acute GVHD treatment trials. | Blood | 2010 | https://conductscience.org/library/papers/20388871 | PubMed |
| 17 | 33351103 | Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin. | Blood Adv | 2020 | https://conductscience.org/library/papers/33351103 | PubMed |
| 18 | 32394392 | GeoMx™ RNA Assay: High Multiplex, Digital, Spatial Analysis of RNA in FFPE Tissue. | Methods Mol Biol | 2020 | https://conductscience.org/library/papers/32394392 | PubMed |
| 19 | 32609561 | Novel In Situ Hybridization and Multiplex Immunofluorescence Technology Combined With Whole-slide Digital Image Analysis in Kidney Transplantation. | J Histochem Cytochem | 2020 | https://conductscience.org/library/papers/32609561 | PubMed |
| 20 | 44107 | Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. | Am J Surg Pathol | 1979 | https://conductscience.org/library/papers/44107 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42367753 | Advances in graft-versus-host disease: emerging therapeutic strategies, biomarker discoveries, and innovative treatment approaches. | Front Immunol | 2026 | https://conductscience.org/library/papers/42367753 | PubMed |
| 42346847 | Spatial Immunology in Translation: Linking Immune Organisation to Therapeutic Outcome. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42346847 | PubMed |
| 41032750 | Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation. | Blood | 2026 | https://conductscience.org/library/papers/41032750 | PubMed |
| 41023441 | The deubiquitinase USP17LA negatively regulates T-cell activation and attenuates anti-tumor immunity. | EMBO Rep | 2025 | https://conductscience.org/library/papers/41023441 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37699201
GET https://conductscience.org/api/papers/v1/37699201/references?page=2